Jia Jie Biomedical Co Ltd (4109) — Working Capital to Net Assets Ratio
Jia Jie Biomedical Co Ltd (4109) has a Working Capital to Net Assets ratio of 23.5% as of December 2025. Working capital of NT$403.64 Million (current assets of NT$574.48 Million minus current liabilities of NT$170.84 Million) is measured against net assets of NT$1.71 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See Jia Jie Biomedical Co Ltd (4109) balance sheet quality index to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Jia Jie Biomedical Co Ltd Working Capital to Net Assets (2015–2025)
This chart shows how Jia Jie Biomedical Co Ltd's Working Capital to Net Assets ratio has evolved across 11 annual periods from 2015 to 2025. As of December 2025, the ratio stands at 23.5%, reflecting working capital of NT$403.64 Million against net assets of NT$1.71 Billion TWD. Check tangible equity quality of Jia Jie Biomedical Co Ltd to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Jia Jie Biomedical Co Ltd (2015–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Jia Jie Biomedical Co Ltd from 2015 to 2025, covering 11 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Jia Jie Biomedical Co Ltd stock valuation.
| Year | WC/NA Ratio | Working Capital (TWD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 23.5% | NT$403.64 Million | NT$1.71 Billion | NT$574.48 Million | NT$170.84 Million | ▲ +6.5 pp |
| 2024 | 17.0% | NT$231.49 Million | NT$1.36 Billion | NT$348.34 Million | NT$116.85 Million | ▲ +7.6 pp |
| 2023 | 9.4% | NT$100.47 Million | NT$1.07 Billion | NT$437.31 Million | NT$336.84 Million | ▼ -17.0 pp |
| 2022 | 26.4% | NT$243.69 Million | NT$923.96 Million | NT$317.21 Million | NT$73.52 Million | ▼ -1.3 pp |
| 2021 | 27.6% | NT$258.36 Million | NT$934.93 Million | NT$340.28 Million | NT$81.93 Million | ▼ -5.5 pp |
| 2020 | 33.1% | NT$300.42 Million | NT$907.97 Million | NT$379.73 Million | NT$79.31 Million | ▲ +26.2 pp |
| 2019 | 6.9% | NT$47.61 Million | NT$694.88 Million | NT$186.64 Million | NT$139.03 Million | ▲ +1.9 pp |
| 2018 | 5.0% | NT$35.58 Million | NT$714.19 Million | NT$425.02 Million | NT$389.44 Million | ▲ +34.1 pp |
| 2017 | -29.2% | NT$-203.99 Million | NT$699.60 Million | NT$389.25 Million | NT$593.25 Million | ▼ -38.8 pp |
| 2016 | 9.6% | NT$92.40 Million | NT$962.54 Million | NT$492.40 Million | NT$400.00 Million | ▼ -0.9 pp |
| 2015 | 10.5% | NT$103.36 Million | NT$983.23 Million | NT$440.85 Million | NT$337.48 Million | — |